Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2003
09/03/2003CN1439378A Preparation for wound hemostatics and suture zipper
09/03/2003CN1439375A 脱氢表雄酮的治疗用途和传送系统 DHEA therapeutic uses and delivery systems
09/03/2003CN1439368A 8-methoxy psoralen gel and its preparing method
09/03/2003CN1439359A Shellfish skin care cosmetics
09/03/2003CN1439357A Herbal skin care paste and its preparing process
09/03/2003CN1120157C Substituted quinoline-2-carboxylic acid amidesuand their preparation and their use as medicaments and intermediate products
09/03/2003CN1120016C Medicine ointment for skin allergy caused by violet ray and cosmetics, dermatitis and other skin diseases
09/03/2003CN1120013C Medicine for baldness caused by liver and kidney dificiency and its preparation
09/03/2003CN1119995C 樟脑搽剂 Camphor liniment
09/03/2003CN1119989C Cosmetic compositions for skin and/or hair photoprotection which are based on sinergic mixture of filters and use thereof
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/02/2003US6613911 Reaction of haloarylacetic acids or esters with olefins to give vinylarylacetic acids or esters, oxidation with an oxidizing reagent gives formylarylacetic acids or esters
09/02/2003US6613905 Chemokine receptor antagonists and methods of use therefor
09/02/2003US6613796 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
09/02/2003US6613778 Imidazopyridine derivatives as phosphodiesterase VII inhibitors
09/02/2003US6613770 Quinoline derivatives as NK-2 and NK-3 receptor ligands
09/02/2003US6613769 Tryptase inhibitors
09/02/2003US6613760 Indole derivatives and their use as MCP-1 receptor antagonists
09/02/2003US6613746 Cell adhesion proteins having cells with glycoprotein antibodies and carbohydrate determinants used to interfere with binding FC receptor and as complement inhibitors; antiinflammatory agents
09/02/2003US6613739 Immunosuppressants
09/02/2003US6613563 Viral vectors with modified tropism
09/02/2003US6613557 Recombinant DNA molecules which encode viral protein; transfecting a host cell with the DNA molecules; used for diagnostic purposes or for incorporation in a vaccine
09/02/2003US6613349 Bactericides
09/02/2003CA2216796C Quinazoline derivatives
08/2003
08/28/2003WO2003070970A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA)
08/28/2003WO2003070969A2 RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070968A2 RNA INTERFERENCE MEDIATED INHIBITION OF GASTRIC INHIBITORY POLYPEPTIDE (GIP) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070918A2 Rna interference by modified short interfering nucleic acid
08/28/2003WO2003070914A2 RNA INTERFERENCE MEDIATED INHIBITION OF FOS GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070911A2 Rna interference mediated inhibition of type 1 insulin-like growth factor receptor (igf-1r)
08/28/2003WO2003070910A2 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070903A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070897A2 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070886A2 Inhibition of protein tyrosine phosphatase type iva expression byshort interfering nucleic acid
08/28/2003WO2003070755A2 Compounds, compositions and method for transporting cyclosporin molecules through the blood brain barrier
08/28/2003WO2003070754A1 Histone deacetylase inhibitors and process for producing the same
08/28/2003WO2003070744A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070730A1 Pyrrolopyrimidine derivative
08/28/2003WO2003070729A1 Pyrrolopyrimidine derivatives
08/28/2003WO2003070727A1 Thiazolyl urea compounds for the treatment of cancer
08/28/2003WO2003070716A1 Vitamin d3 derivatives and remedies using the same
08/28/2003WO2003070711A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
08/28/2003WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation
08/28/2003WO2003070277A1 Antipruritics
08/28/2003WO2003070260A1 A photoprotective orally administrable composition for skin
08/28/2003WO2003070252A1 Antipruritics
08/28/2003WO2003070251A1 Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2003WO2003070249A1 Combination consisting of trapidil and serotonin antagonists such as cyproheptadine or pizotifen for inhibiting angiogenesis
08/28/2003WO2003070242A1 Piperidin-4-yl urea derivatives and related compounds as chemokine receptor inhibitors for the treatment of inflammatory diseases
08/28/2003WO2003070237A1 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
08/28/2003WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070231A1 Antibacterial compositions
08/28/2003WO2003070204A2 Lipase inhibiting composition
08/28/2003WO2003070203A1 Orally administrable composition for the photoprotection of the skin
08/28/2003WO2003070197A2 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
08/28/2003WO2003070192A2 Compositions and methods for surrogate antibody modulation of an immune response and transport
08/28/2003WO2003070190A2 Surrogate antibodies and methods of preparation and use thereof
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003WO2003070184A2 Sodium channel blockers
08/28/2003WO2003070182A2 Sodium channel blockers
08/28/2003WO2003070180A2 Compositions and methods for delivery of skin cosmeceuticals
08/28/2003WO2003070166A2 Novel tyloindicines and related processes, pharmaceutical compositions and methods
08/28/2003WO2003070153A2 Stabilized pharmaceutical compositions of halofuginone and other quinazolinone derivatives
08/28/2003WO2003070019A1 Pet food composition for skin photoprotection
08/28/2003WO2003069997A1 Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
08/28/2003WO2003037384A3 Polymer conjugates of protein kinase c inhibitors
08/28/2003WO2003027116A3 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives
08/28/2003WO2003026602A3 Medicine for preventing and treating bromidrosis
08/28/2003WO2003025015A3 A soluble toll-like receptor
08/28/2003WO2003024454A3 Topical composition containing brucine and the use for the treatment of damaged mammalian skin
08/28/2003WO2003016335A3 Irreversible cysteine protease inhibitors of legumain
08/28/2003WO2003013434A3 Methods and compositions for treating diseases associated with excesses in ace
08/28/2003WO2003011239A3 Sunscreen composition
08/28/2003WO2002102990A3 Fibroblast growth factor and nucleic acid encoding same
08/28/2003WO2002094192A3 Antibodies against tumor necrosis factor delta (april)
08/28/2003WO2002081521A3 Osteoprotegerin in milk
08/28/2003WO2002081508A3 Use of cd25 binding molecules in steroid-resistant patients
08/28/2003WO2002074337A8 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
08/28/2003WO2002072534A3 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof
08/28/2003WO2002053773A3 Method for determining skin stress or skin ageing in vitro
08/28/2003WO2002046749A3 Screening method for identifying compounds that selectively induce interferon alpha
08/28/2003WO2002036149A3 Methods for obtaining inhibitors of t-cell membrane protein (tirc7) ligand binding and uses thereof
08/28/2003WO2002034940A3 Methods for screening compounds that modulate lipid metabolism
08/28/2003WO2002015885A3 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
08/28/2003WO2001095859A3 Novel heterocyclic analogs of diphenylethylene compounds
08/28/2003US20030163845 Elongase genes and uses thereof
08/28/2003US20030163834 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162954 Antitumor agents; gastrointestinal disorders
08/28/2003US20030162836 Microbiocides
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/28/2003US20030162821 Applying topical mixtures of allantoin, emulsifiers and optionally steroids, nonsteroidal antiinflammatory agents, leukotriene antagonists or monoclonal antibodies, to prevent scarring, ulcers or blisters on skins
08/28/2003US20030162819 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162801 Tricyclic compounds and their uses
08/28/2003US20030162798 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments
08/28/2003US20030162775 Heterocyclic substituted pyrazolones
1 ... 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 ... 1065